The Scientific Advisory Board (SAB) provides strategic guidance and direction for our research and scientific programs. It plays a key role in guiding and prioritizing Oncoheroes' research investment.
Peter Adamson, MD, PhD
Global Head, Oncology Development & Pediatric Innovation, Sanofi
Pratiti Bandopadhayay MBBS, PhD
Pediatric Neuro-Oncologist, Dana Farber Cancer Institute, Boston
Instructor in Pediatrics, Harvard School
Steven Dubois MD, MS
Director Experimental Therapeutics
Dana Farber Cancer Institute, Boston
Associate Professor of Pediatrics, Harvard School
Juliet Gray MD, MA, MB BS, MRCPCH, PhD
Clinical Lead Pediatric Oncology & Hematology Pediatric Oncology Clinical Trials Lead
Southampton Paediatric Oncology Centre
Lee J. Helman, MD
Professor University of Southern California
Head Basic and Translational Research Children’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles
Daniel Morgenstern, MD, PhD
Department of Pediatric Oncology, Sick Children Hospital, Toronto, Canada
Assistant Professor, University of Toronto